alendronate has been researched along with Pyrosis in 2 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Binkley, N | 1 |
| Martens, MG | 1 |
| Silverman, SL | 1 |
| Derman, RJ | 1 |
| Greenwald, M | 1 |
| Kohles, JD | 1 |
| Bachmann, GA | 1 |
| Blümel, JE | 1 |
| Castelo-Branco, C | 1 |
| de la Cuadra, G | 1 |
| Maciver, L | 1 |
| Moreno, M | 1 |
| Haya, J | 1 |
2 trials available for alendronate and Pyrosis
| Article | Year |
|---|---|
Improved GI tolerability with monthly ibandronate in women previously using weekly bisphosphonates.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; | 2009 |
Alendronate daily, weekly in conventional tablets and weekly in enteric tablets: preliminary study on the effects in bone turnover markers and incidence of side effects.
Topics: Administration, Oral; Adult; Alendronate; Bone Density; Collagen Type I; Drug Administration Schedul | 2003 |